Join the Hypertension group to help and get support from people like you.
Hypertension News (Page 8)
Intensive Inpatient BP Management Not Beneficial in Seniors
WEDNESDAY, June 21, 2023 – For hospitalized older adults with elevated blood pressure (BP), intensive antihypertensive treatment is associated with an increased risk for adverse events, according to...
Know Your Blood Pressure Numbers and What They Mean
TUESDAY, June 20, 2023 – You could have high blood pressure and not realize it. The only way to know for sure is to have your blood pressure tested. It’s an important step, according to the American ...
Risk of Hypertension Up With Use of Oral Estrogen-Only Hormone Therapy
THURSDAY, June 8, 2023 – For postmenopausal women using estrogen-only hormone therapy (HT), oral estrogen-only HT use is associated with increased risk of hypertension, according to a study...
One Form of Menopause Hormone Therapy Might Raise Blood Pressure
MONDAY, June 5, 2023 – Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests. The s...
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...
FDA Medwatch Alert: Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level....
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials
ISSUE: Hospira is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus (NDC...
Medicure Announces FDA Approval Received for Prexxartan (valsartan) Oral Solution
WINNIPEG, Dec. 19, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that Carmel Biosciences, Inc. ("Carmel") has...
Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
DUBLIN, Nov. 15, 2017 /PRNewswire/ – Noden Pharma DAC, a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas,...
CMP Pharma, Inc. Announces FDA Approval of CaroSpir (spironolactone) Oral Suspension
Farmville, NC. August 7, 2017 – CMP Pharma today announced that the US Food and Drug Administration (FDA) has granted final approval of the company’s New Drug Application (NDA) for CaroSpir (Sp...
FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older
Denver, July 29, 2016 — Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...
Allergan Announces FDA Approval of Byvalson (nebivolol and valsartan) for Hypertension
DUBLIN, June 6, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the approval of Byvalson (nebivolol and valsartan) 5 mg/ 80 mg tablets, by the...
FDA Approves Prestalia (amlodipine and perindopril) for Hypertension
CINCINNATI & BEND, Ore., January 26, 2015 --(BUSINESS WIRE)--Symplmed Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Prestalia (perindopril arginine and...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Cardiovascular Conditions and Disorders
Related drug support groups
lisinopril, metoprolol, amlodipine, propranolol, losartan, atenolol, hydrochlorothiazide, spironolactone, clonidine, view more... carvedilol, Metoprolol Succinate ER, Bystolic, diltiazem, Lasix, Metoprolol Tartrate, furosemide, bisoprolol, valsartan, Norvasc, ramipril, prazosin, guanfacine, Benicar, Coreg, Diovan, verapamil, nitroglycerin